XML 52 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-based Compensation (Tables)
3 Months Ended
Sep. 30, 2017
Share-based Compensation  
Schedule of weighted average assumptions used to estimate fair values of the stock options granted and the estimated annual forfeiture rates used to recognize the associated compensation expense and the weighted average fair value of the options granted

 

 

September 30,
2017

 

September 30,
2016

 

Risk-free interest rate

 

1.9

%

1.1

%

Expected volatility

 

57.4

%

55.6

%

Expected dividend yield

 

 

 

Forfeiture rate

 

6.5

%

6.5

%

Expected term (in years)

 

5.4 years

 

5.2 years

 

Weighted average fair value

 

$

9.06

 

$

15.33

 

 

Summary of stock option award activity

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Weighted-

 

 

 

Average

 

 

 

 

 

Average

 

Aggregate

 

Remaining

 

 

 

 

 

Exercise

 

Intrinsic

 

Contractual

 

(In thousands, except for weighted average price and life data)

 

Awards

 

Price

 

Value

 

Life (yrs.)

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2017

 

1,475

 

$

18.02

 

$

12,212

 

5.7

 

Granted

 

18

 

$

17.40

 

 

 

 

 

Exercised

 

(14

)

$

6.53

 

$

150

 

 

 

Forfeited, expired or repurchased

 

(6

)

$

26.55

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2017

 

1,473

 

$

18.09

 

$

10,075

 

5.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at September 30, 2017

 

1,470

 

$

18.07

 

$

10,073

 

5.5

 

Exercisable at September 30, 2017

 

1,436

 

$

17.66

 

$

10,057

 

5.4

 

 

Summary of nonvested restricted stock awards

(In thousands, except for weighted average price data)

 

Awards

 

Weighted
Average Grant -
date Fair Value

 

Aggregate
Intrinsic Value

 

 

 

 

 

 

 

 

 

Non-vested at June 30, 2017

 

334

 

$

30.71

 

 

 

Granted

 

460

 

17.16

 

 

 

Vested

 

(116

)

35.35

 

$

2,452

 

Forfeited

 

(17

)

24.13

 

 

 

 

 

 

 

 

 

 

 

Non-vested at September 30, 2017

 

661

 

$

39.72

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of allocation of share-based compensation costs recognized in the Consolidated Statements of Operations by financial statement line item

 

 

Three Months Ended
September 30,

 

(In thousands)

 

2017

 

2016

 

Selling, general and administrative

 

$

1,787

 

$

1,972

 

Research and development

 

151

 

173

 

Cost of sales

 

251

 

311

 

 

 

 

 

 

 

Total

 

$

2,189

 

$

2,456

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax benefit at statutory rate

 

$

799

 

$

897